Search
Type 1 Diabetes Clinical Trials in Walnut Creek, CA
A listing of 2 Type 1 Diabetes clinical trials in Walnut Creek, CA actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 2 of 2
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Type 1 Diabetes
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The city of Walnut Creek, California, currently has 2 active clinical trials seeking participants for Type 1 Diabetes research studies.
Featured Trial
Healthy Participants Needed (Colonoscopy + Cancer Screening)
Recruiting
Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
Conditions:
Healthy
Healthy Volunteers
Healthy Subjects
Healthy Volunteer
Healthy Participants
Featured Trial
Chronic Kidney Disease Clinical Study
Recruiting
We are seeking individuals of African descent interested in a clinical study investigating an investigational treatment for chronic kidney disease caused by genetic factors that primarily affect people of African descent, specifically focusing on APOL-1 mediated kidney disease.
Conditions:
Chronic Kidney Disease
Chronic Kidney Diseases
Chronic Kidney Failure
Chronic Kidney Disease (CKD)
Chronic Kidney Disease(CKD)
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Conditions:
Healthy
Healthy Volunteer Study
Featured Trial
COVID Vaccine Age 50-64 Study (Up to $710 Total Compensation)
Recruiting
Multiple COVID-19 investigational vaccine studies are now enrolling participants (Age 50-64), with appointments available. Participants who qualify may receive up to $710 in total compensation.
If eligible, participants may be matched to one of the current COVID-19 vaccine studies. Should you express interest, the study team will contact you directly to provide further details and answer any questions about study procedures, time commitment, potential risks/benefits, and compensation.
If eligible, participants may be matched to one of the current COVID-19 vaccine studies. Should you express interest, the study team will contact you directly to provide further details and answer any questions about study procedures, time commitment, potential risks/benefits, and compensation.
Conditions:
COVID Vaccine (Age 50-64)
COVID
COVID-19
COVID19
COVID 19
Featured Trial
Vaccine (18+) Clinical Study
Recruiting
We are seeking healthy individuals aged 18 and above who are interested in participating in a vaccine clinical trial.
Conditions:
Vaccine (18+)
Healthy
Healthy Individuals
Healthy Volunteers
Healthy Subjects
Featured Trial
Vaccine (65+) Clinical Study
Recruiting
We are seeking healthy participants aged 65 and above who are interested in participating in a vaccine clinical trial.
Conditions:
Vaccine (65+)
Healthy
Older Adults
Seniors
Healthy Volunteers
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Recruiting
This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 208-day study consists of a Screening Period (28 days), Treatment Period (90 days), and Post-Dose Evaluations (90 days).
Gender:
ALL
Ages:
Between 12 years and 35 years
Trial Updated:
07/17/2025
Locations: Diablo Clinical Research, Walnut Creek, California
Conditions: Type 1 Diabetes Mellitus, T1D, T1DM, T1DM - Type 1 Diabetes Mellitus, Type 1 Diabetes in Adolescence, Type 1 Diabetes in Children, Type 1 Diabetes (Juvenile Onset), Type 1 Diabetes, Type 1 Diabetes Patients, Type 1 Diabetes Mellitis
Safety and Effectiveness of the Luna System in People with Type 1 Diabetes Mellitus
Recruiting
The purpose of this research is to evaluate the effect of a wearable insulin pump on blood sugar levels during sleep. The study device works with continuous glucose monitors (CGM) to calculate and deliver rapid-acting insulin doses during sleep. The study device does not replace long-acting, correction, or mealtime insulin. The study will involve applying the study device before bed for a period of 13 weeks. The overall study length is approximately 17 weeks.
The study aims to evaluate whether... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/17/2025
Locations: Diablo Clinical Research, Walnut Creek, California
Conditions: Type 1 Diabetes Mellitus, Sleep Quality
1 - 2 of 2